These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37139652)

  • 1. Alternative options for treatment-experienced people with HIV.
    Slama L; Hardy WD; Quiñones-Mateu ME; Kuritzkes DR
    AIDS; 2023 Jun; 37(7):1165-1166. PubMed ID: 37139652
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
    Wilson LE; Gallant JE
    Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Getting the most from available antiretroviral therapies.
    Highleyman L
    BETA; 2008; 20(4):14-6. PubMed ID: 18814370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third line anti-HIV therapy options.
    Proj Inf Perspect; 2004 Jan; (37):19-21. PubMed ID: 15119286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Becoming a positive parent: reproductive options for people with HIV.
    Leggett H
    BETA; 2011; 23(2):43-52. PubMed ID: 22567822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of being earnest. Specific advantages and new treatment options for the un-undetectable.
    Berger DS
    Posit Aware; 2007; 18(2):37. PubMed ID: 17390490
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV antiretroviral agents.
    Gallant JE
    Posit Aware; 1999; 10(1):25. PubMed ID: 11366517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing and interpreting HIV noninferiority trials in naive and experienced patients.
    Hill A; Sabin C
    AIDS; 2008 May; 22(8):913-21. PubMed ID: 18453850
    [No Abstract]   [Full Text] [Related]  

  • 9. International HIV Workshop on Management of Treatment-Experienced Patients.
    Bartlett JG
    Hopkins HIV Rep; 2002 Nov; 14(6):4-5. PubMed ID: 12491990
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of etravirine for treatment of acute HIV meningoencephalitis.
    Couzigou C; Seang S; Morand-Joubert L; Roque-Afonso AM; Escaut L; Vittecoq D
    Clin Infect Dis; 2009 Mar; 48(6):e62-5. PubMed ID: 19193114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy.
    Muccini C; Canetti D; Castagna A; Spagnuolo V
    Drug Des Devel Ther; 2022; 16():297-304. PubMed ID: 35115764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized HIV therapy to control drug resistance.
    Lengauer T; Pfeifer N; Kaiser R
    Drug Discov Today Technol; 2014 Mar; 11():57-64. PubMed ID: 24847654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barcelona reports on people with HIV emphasize treatment issues.
    Johnson MO
    Focus; 2002 Oct; 17(11):5-6. PubMed ID: 12532912
    [No Abstract]   [Full Text] [Related]  

  • 14. Report from the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Maraviroc in treatment-experienced and treatment-naive patients.
    AIDS Clin Care; 2007 Oct; 19(10):83-4. PubMed ID: 18401879
    [No Abstract]   [Full Text] [Related]  

  • 15. Meeting report from the 2nd International HIV Workshop on Management of Treatment-Experienced Patients. September 26-27 2002, San Diego, Calif., USA.
    Montaner J; Mellors J
    Antivir Ther; 2002; 7 Suppl 2():S217-33. PubMed ID: 12699127
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel treatment options for pediatric HIV infection.
    Day E; Buckberry K; Sharland MR; Chakraborty R
    Curr Opin Investig Drugs; 2008 Feb; 9(2):170-5. PubMed ID: 18246519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment options to be examined in 9-year study.
    AIDS Policy Law; 2002 Feb; 17(2):2. PubMed ID: 11851127
    [No Abstract]   [Full Text] [Related]  

  • 18. Report from the 14th Retrovirus Conference. Treatment options for antiretroviral-naive patients.
    Sax PE
    AIDS Clin Care; 2007 May; 19(5):38-9. PubMed ID: 18401876
    [No Abstract]   [Full Text] [Related]  

  • 19. Report from the 15th Retrovirus Conference. Durability of new agents for treatment-experienced patients.
    Albrecht H
    AIDS Clin Care; 2008 Apr; 20(4):30. PubMed ID: 19266669
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment options for HIV, AIDS.
    FDA Consum; 2004; 38(6):4. PubMed ID: 15675011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.